Your browser doesn't support javascript.
loading
The efficacy of the treat-repair-treat strategy for severe pulmonary arterial hypertension associated with congenital heart disease: a meta-analysis.
Wang, Zhiyuan; Li, Xiaobing; Li, Mengxuan; Peng, Jun; Zhang, Huijun.
Affiliation
  • Wang Z; Department of Cardiac Surgery, The First Hospital of Hebei Medical University, No. 89, Donggang Road, Yuhua District, Shijiazhuang City, Hebei Province, China.
  • Li X; Department of Cardiac Surgery, The First Hospital of Hebei Medical University, No. 89, Donggang Road, Yuhua District, Shijiazhuang City, Hebei Province, China.
  • Li M; Department of Cardiac Surgery, The First Hospital of Hebei Medical University, No. 89, Donggang Road, Yuhua District, Shijiazhuang City, Hebei Province, China.
  • Peng J; Department of Cardiac Surgery, The First Hospital of Hebei Medical University, No. 89, Donggang Road, Yuhua District, Shijiazhuang City, Hebei Province, China.
  • Zhang H; Department of Cardiac Surgery, The First Hospital of Hebei Medical University, No. 89, Donggang Road, Yuhua District, Shijiazhuang City, Hebei Province, China. zhanghuijunwzy@163.com.
BMC Cardiovasc Disord ; 23(1): 569, 2023 11 20.
Article in En | MEDLINE | ID: mdl-37986143
ABSTRACT

BACKGROUND:

This meta-analysis was conducted to evaluate the efficacy of the treat-repair-treat (TRT) strategy in the treatment of severe pulmonary arterial hypertension with congenital heart disease (PAH-CHD).

METHODS:

PubMed, EMBASE, Cochrane and Web of Science online databases were searched by two independent investigators for studies that used the TRT strategy for PAH-CHD, and the retrieved studies were reviewed by a third investigator. The main outcomes were pulmonary artery pressure (PAP), pulmonary vascular resistance (PVR), 6-minute walk distance (6MWD), and transcutaneous oxygen saturation (SpO2). The changes were compared between follow-up and baseline. Stata version 14.0 was used for data analysis. A random-effects model was selected for meta-analysis. Subgroup analysis and meta-regression were used to find the source of heterogeneity.

RESULTS:

A total of 335 patients from 9 single-arm studies were included. Meta-analysis showed significant reductions in PAP and PVR and improvements in 6MWD and SpO2 (PAP SMD -2.73 95% CI -2.97, - 2.50 p = < 0.001; PVR SMD -1.27 95% CI -1.53, - 1.02 p = < 0.001; 6MWD SMD 1.88 95% CI 1.49, 2.27 p = < 0.001; SpO2 SMD 3.72 95% CI 3.13, 4.32 p = < 0.001). Subgroup analysis showed that younger patients had better efficacy, and the change in SpO2 was an indication for patient selection. The combined mortality rate was 5% at follow-up.

CONCLUSIONS:

In this meta-analysis, we demonstrated that the TRT strategy may have positive effects on haemodynamics and cardiac function in patients with severe PAH-CHD at short-term follow-up. Our analysis suggests that changes in age and SpO2 may be related to patient prognosis. TRIAL REGISTRATION The protocol was registered on the PROSPERO website with the registration number CRD42022366552. The relevant registration information can be obtained from the website https//www.crd.york.ac.uk/prospero/#searchadvanced .
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pulmonary Arterial Hypertension / Heart Defects, Congenital / Hypertension, Pulmonary Type of study: Systematic_reviews Limits: Humans Language: En Journal: BMC Cardiovasc Disord Journal subject: ANGIOLOGIA / CARDIOLOGIA Year: 2023 Type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pulmonary Arterial Hypertension / Heart Defects, Congenital / Hypertension, Pulmonary Type of study: Systematic_reviews Limits: Humans Language: En Journal: BMC Cardiovasc Disord Journal subject: ANGIOLOGIA / CARDIOLOGIA Year: 2023 Type: Article Affiliation country: China